ARTICLE | Company News
ChronTech infectious, drug delivery news
May 13, 2013 7:00 AM UTC
ChronTech said that a group of shareholders offered to acquire all assets related to ChronTech's development programs for DNA vaccines against HBV and HCV for $1 million. The shareholders have formed ...